John P. Galvin

1.6k total citations
64 papers, 531 citations indexed

About

John P. Galvin is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Religious studies. According to data from OpenAlex, John P. Galvin has authored 64 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 12 papers in Religious studies. Recurrent topics in John P. Galvin's work include Hematopoietic Stem Cell Transplantation (18 papers), Acute Lymphoblastic Leukemia research (11 papers) and Biblical Studies and Interpretation (9 papers). John P. Galvin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), Acute Lymphoblastic Leukemia research (11 papers) and Biblical Studies and Interpretation (9 papers). John P. Galvin collaborates with scholars based in United States, United Kingdom and Italy. John P. Galvin's co-authors include Francis Schüssler Fiorenza, Wayne G. Rollins, Gerd Theißen, Jingbo Yu, Baikun Wang, C. Erik Hack, Christopher J. Froelich, Prem Seth, Karen Sheehan and Suzanne T. Ildstad and has published in prestigious journals such as Blood, The Journal of Immunology and Langmuir.

In The Last Decade

John P. Galvin

48 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Galvin United States 13 162 99 86 81 63 64 531
Gillian Huang Australia 10 193 1.2× 81 0.8× 27 0.3× 40 0.5× 43 0.7× 21 413
Celia Grosskreutz United States 8 72 0.4× 125 1.3× 34 0.4× 21 0.3× 44 0.7× 12 358
Huib de Jong Netherlands 12 24 0.1× 76 0.8× 74 0.9× 50 0.6× 7 0.1× 22 394
Patrick Elder United States 17 380 2.3× 166 1.7× 31 0.4× 126 1.6× 13 0.2× 71 768
S Chiodi Italy 10 229 1.4× 72 0.7× 15 0.2× 42 0.5× 37 0.6× 17 500
Orly R. Klein United States 11 138 0.9× 67 0.7× 18 0.2× 26 0.3× 13 0.2× 25 286
Yvonne Barnes United States 9 179 1.1× 57 0.6× 17 0.2× 33 0.4× 12 0.2× 22 354
Paul M. Schroder United States 19 34 0.2× 200 2.0× 279 3.2× 112 1.4× 13 0.2× 57 982
Xiong Ni China 10 345 2.1× 233 2.4× 11 0.1× 75 0.9× 7 0.1× 51 640
Beverly Rhodes United States 5 187 1.2× 99 1.0× 13 0.2× 8 0.1× 14 0.2× 9 300

Countries citing papers authored by John P. Galvin

Since Specialization
Citations

This map shows the geographic impact of John P. Galvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Galvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Galvin more than expected).

Fields of papers citing papers by John P. Galvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Galvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Galvin. The network helps show where John P. Galvin may publish in the future.

Co-authorship network of co-authors of John P. Galvin

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Galvin. A scholar is included among the top collaborators of John P. Galvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Galvin. John P. Galvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Epperla, Narendranath, et al.. (2024). REAL-WORLD SEQUENTIAL USE OF CD19-DIRECTED THERAPIES FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: TAFASITAMAB PRECEDING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY. Hematology Transfusion and Cell Therapy. 46. S226–S226. 1 indexed citations
3.
Mahmoudjafari, Zahra, Valkal Bhatt, John P. Galvin, et al.. (2024). Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease. Bone Marrow Transplantation. 60(1). 69–78. 1 indexed citations
4.
Yu, Jingbo, Nandita Khera, James Turnbull, et al.. (2023). Impact of Chronic Graft-versus-Host Disease on Patient Employment, Income, and Informal Caregiver Burden: Findings From the Living With Chronic GVHD Patient Survey. Transplantation and Cellular Therapy. 29(7). 470.e1–470.e9. 6 indexed citations
5.
Holtan, Shernan G., Jingbo Yu, Hannah Choe, et al.. (2022). Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review. Bone Marrow Transplantation. 57(10). 1581–1585. 23 indexed citations
6.
Holtan, Shernan G., Jingbo Yu, Dilan Paranagama, et al.. (2022). Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study. Bone Marrow Transplantation. 57(9). 1399–1404. 9 indexed citations
7.
Rubinstein, P, et al.. (2022). CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report. Diagnostic Pathology. 17(1). 53–53. 3 indexed citations
8.
Bell, Elizabeth J., Jingbo Yu, Valkal Bhatt, et al.. (2022). Healthcare Resource Utilization and Costs of Steroid-Associated Complications in Patients With Graft-Versus-Host Disease. Transplantation and Cellular Therapy. 28(10). 707.e1–707.e7. 6 indexed citations
9.
Abraham, Ivy, Anand Patel, John P. Galvin, et al.. (2021). Impact of race on outcomes in intermediate-risk acute myeloid leukemia. Cancer Causes & Control. 32(7). 705–712. 9 indexed citations
10.
Broglie, Larisa, Alfred Rademaker, John P. Galvin, et al.. (2018). Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease. Hematology/Oncology and Stem Cell Therapy. 11(3). 169–174. 3 indexed citations
11.
Gupta, Vikas, Heidi Kosiorek, Adam J. Mead, et al.. (2018). Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. Biology of Blood and Marrow Transplantation. 25(2). 256–264. 39 indexed citations
12.
Hunt, Eoin, et al.. (2018). Gastric Aspiration and Its Role in Airway Inflammation. The Open Respiratory Medicine Journal. 12(1). 1–10. 31 indexed citations
13.
Ehrlich, Katherine B., et al.. (2016). Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 51(12). 1594–1598. 32 indexed citations
14.
Trifilio, Steven, et al.. (2015). Tbo or Not Tbo-That Is the Question!. Biology of Blood and Marrow Transplantation. 21(2). S260–S260. 1 indexed citations
15.
Leventhal, Joseph R., Mary Jane Elliott, Esma S. Yolcu, et al.. (2015). Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants. Transplantation. 99(2). 288–298. 88 indexed citations
16.
Galvin, John P.. (2013). The Uniqueness of Jesus. Proceedings of the Catholic Theological Society of America (Catholic Theological Society of America). 35.
17.
Galvin, John P., Jessica K. Altman, Dennis J. Goussetis, et al.. (2013). Regulation of the kinase RSK1 by arsenic trioxide and generation of antileukemic responses. Cancer Biology & Therapy. 14(5). 411–416. 9 indexed citations
18.
Sheehan, Karen, et al.. (2004). Urban Children's Perceptions of Violence. Archives of Pediatrics and Adolescent Medicine. 158(1). 74–74. 23 indexed citations
19.
Heywood, Frances, et al.. (1999). Housing options for older people. UWE Research Repository (UWE Bristol). 5 indexed citations
20.
Balch, David L., et al.. (1987). Jesus and Community: The Social Dimension of Christian Faith. Journal of Biblical Literature. 106(4). 715–715. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian Huang Breakdown of academic impact, for papers by Celia Grosskreutz Breakdown of academic impact, for papers by Huib de Jong Breakdown of academic impact, for papers by Patrick Elder Breakdown of academic impact, for papers by S Chiodi Breakdown of academic impact, for papers by Orly R. Klein Breakdown of academic impact, for papers by Yvonne Barnes Breakdown of academic impact, for papers by Paul M. Schroder Breakdown of academic impact, for papers by Xiong Ni Breakdown of academic impact, for papers by Beverly Rhodes
Rankless by CCL
2026